Covidien launches Nellcor SpO2 single parameter module for use with Phillips IntelliVue patient monitoring platform.
January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...
This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
Receiving FDA clearance for Nellcor with Nell-EQ could help Medtronic as it competes with Masimo for the pulse oximetry ...
- Nellcor™ Pulse Oximetry Technology Demonstrated Statistically Significant Difference in Time to Deliver a Stable Oxygen Saturation Value and Heart Rate According to the study, a stable signal was ...
Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.
June 8, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ ...
This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results